PARIS, FRANCE (UroToday.com) - The increasing attention to vesicovaginal fistulae (VVF) in the developing world continued with the first presentation of the afternoon by Dr. DeRidder. He noted the challenges in this area with respect to presenting levels of evidence and recommendation grades due to a scarcity of randomized controlled trials and high-level evidence.
E-Mail this Story
PARIS, FRANCE (UroToday.com) - The increasing attention to vesicovaginal fistulae (VVF) in the developing world continued with the first presentation of the afternoon by Dr. DeRidder. He noted the challenges in this area with respect to presenting levels of evidence and recommendation grades due to a scarcity of randomized controlled trials and high-level evidence.
